These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
500 related articles for article (PubMed ID: 20093143)
21. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil. da Luz Becker D; dos Santos O; Frasson AP; de Vargas Rigo G; Macedo AJ; Tasca T Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539 [TBL] [Abstract][Full Text] [Related]
22. A reassessment of the role of oxygen scavenging enzymes in the emergence of metronidazole resistance in trichomonads. Gehl V; Paunkov A; Leitsch D Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():38-44. PubMed ID: 33962363 [TBL] [Abstract][Full Text] [Related]
23. Differential inhibition of high and low Mr thioredoxin reductases of parasites by organotelluriums supports the concept that low Mr thioredoxin reductases are good drug targets. McMillan PJ; Patzewitz EM; Young SE; Westrop GD; Coombs GH; Engman L; Müller S Parasitology; 2009 Jan; 136(1):27-33. PubMed ID: 18980703 [TBL] [Abstract][Full Text] [Related]
24. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614 [TBL] [Abstract][Full Text] [Related]
25. In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis. Blaha C; Duchêne M; Aspöck H; Walochnik J J Antimicrob Chemother; 2006 Feb; 57(2):273-8. PubMed ID: 16344287 [TBL] [Abstract][Full Text] [Related]
26. Antioxidant defences in the microaerophilic protozoan Trichomonas vaginalis: comparison of metronidazole-resistant and sensitive strains. Ellis JE; Yarlett N; Cole D; Humphreys MJ; Lloyd D Microbiology (Reading); 1994 Sep; 140 ( Pt 9)():2489-94. PubMed ID: 7952198 [TBL] [Abstract][Full Text] [Related]
27. Mycoplasma hominis impacts gene expression in Trichomonas vaginalis. Fürnkranz U; Henrich B; Walochnik J Parasitol Res; 2018 Mar; 117(3):841-847. PubMed ID: 29368037 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of in vitro development of resistance to metronidazole in Trichomonas vaginalis. Rasoloson D; Vanacova S; Tomkova E; Razga J; Hrdy I; Tachezy J; Kulda J Microbiology (Reading); 2002 Aug; 148(Pt 8):2467-2477. PubMed ID: 12177340 [TBL] [Abstract][Full Text] [Related]
30. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea. Upcroft JA; Dunn LA; Wal T; Tabrizi S; Delgadillo-Correa MG; Johnson PJ; Garland S; Siba P; Upcroft P Sex Health; 2009 Dec; 6(4):334-8. PubMed ID: 19917203 [TBL] [Abstract][Full Text] [Related]
31. The Role of Iron Status in the Early Progression of Metronidazole Resistance in Trichomonas vaginalis Under Microaerophilic Conditions. Argáez-Correa W; Alvarez-Sánchez ME; Arana-Argáez VE; Ramírez-Camacho MA; Novelo-Castilla JS; Coral-Martínez TI; Torres-Romero JC J Eukaryot Microbiol; 2019 Mar; 66(2):309-315. PubMed ID: 30047563 [TBL] [Abstract][Full Text] [Related]
32. [In vitro effect of metronidazole ester on Trichomonas vaginalis and Entamoeba histolytica]. He Y; Tao X; Guan L; Lian W Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(1):32-4. PubMed ID: 7788891 [TBL] [Abstract][Full Text] [Related]
33. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis. Küng E; Pietrzak J; Klaus C; Walochnik J Int J Antimicrob Agents; 2016 Mar; 47(3):232-4. PubMed ID: 26899578 [TBL] [Abstract][Full Text] [Related]
34. Potential of bisbenzimidazole-analogs toward metronidazole-resistant Trichomonas vaginalis isolates. Korosh T; Bujans E; Morada M; Karaalioglu C; Vanden Eynde JJ; Mayence A; Huang TL; Yarlett N Chem Biol Drug Des; 2017 Oct; 90(4):489-495. PubMed ID: 28296056 [TBL] [Abstract][Full Text] [Related]
35. S-Adenosylhomocysteine hydrolase of the protozoan parasite Trichomonas vaginalis: potent inhibitory activity of 9-(2-deoxy-2-fluoro-β,D-arabinofuranosyl)adenine. Shokar A; Au A; An SH; Tong E; Garza G; Zayas J; Wnuk SF; Land KM Bioorg Med Chem Lett; 2012 Jun; 22(12):4203-5. PubMed ID: 22579483 [TBL] [Abstract][Full Text] [Related]
37. [Metronidazole resistance test in vitro in strains of Trichomonas vaginalis isolated from clinical material. 2. Proposal for a standard tests]. Tachezy J; Kulda J Cesk Epidemiol Mikrobiol Imunol; 1991 Mar; 40(2):97-104. PubMed ID: 1827367 [TBL] [Abstract][Full Text] [Related]
38. [Metronidazole resistance test in vitro in strains of Trichomonas vaginalis isolated from clinical material. 1. Test conditions]. Tachezy J; Kulda J Cesk Epidemiol Mikrobiol Imunol; 1991 Mar; 40(2):89-96. PubMed ID: 1827366 [TBL] [Abstract][Full Text] [Related]
39. In vitro induced anaerobic resistance to metronidazole in Trichomonas vaginalis. Kulda J; Tachezy J; Cerkasovová A J Eukaryot Microbiol; 1993; 40(3):262-9. PubMed ID: 8508165 [TBL] [Abstract][Full Text] [Related]
40. In vitro susceptibility of Trichomonas vaginalis to AT-specific minor groove binding drugs. Chavalitshewinkoon-Petmitr P; Ramdja M; Kajorndechakiat S; Ralph RK; Denny WA; Wilairat P J Antimicrob Chemother; 2003 Aug; 52(2):287-9. PubMed ID: 12837730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]